Synonyms: LY-2062430
Compound class:
Antibody
Comment: Solanezumab is an investigational humanized monoclonal antibody targeting amyloid-β (Aβ).
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. The invention of solanezumab is covered by patent US7195761 [2], where it is coded as Hu266. |
Classification ![]() |
|
Compound class | Antibody |
International Nonproprietary Names ![]() |
|
INN number | INN |
9097 | solanezumab |
Synonyms ![]() |
LY-2062430 |
Database Links ![]() |
|
Specialist databases | |
IMGT/mAb-DB | 298 |
Other databases | |
GtoPdb PubChem SID | 178103514 |
PubChem SID | 178103514 |
Search PubMed clinical trials | solanezumab |
Search PubMed titles | solanezumab |
Search PubMed titles/abstracts | solanezumab |
Wikipedia | Solanezumab |